Aditxt, Inc. Gain (Loss) on Disposition of Assets
Aditxt, Inc. (ADTX) reported Gain (Loss) on Disposition of Assets of -$3.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-03-31
- Aditxt, Inc. gain (loss) on disposition of assets for fiscal 2024 was -$3.00K.
- Aditxt, Inc. gain (loss) on disposition of assets for fiscal 2022 was -$6.98K.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2024-12-31 | -$3.00K 10-K · filed 2026-03-31 |
| 2022-12-31 | -$6.98K 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |